Search Within

GME, Medicine

Formats
  1. Meeting Abstract (682)
  2. Journal Article (534)
  3. Review (141)
  4. Editorial (64)
  5. Research Letter (56)
  6. Correspondence (24)
  7. Miscellaneous (6)
  8. Book Section (5)
  9. Conference Paper (4)
  10. Guidelines (3)
Groups
  1. Graduate Medical Education (1519)
  2. Department of Medicine (1192)
  3. Hematology-Oncology Fellows (992)
  4. Hematologic Malignancies, Division of (699)
  5. Solid Tumor Oncology Division (609)
  6. Weinberg Fellows (567)

More Groups

People
  1. Kylee Maclachlan (143)
  2. Gunjan Shah (135)
  3. Michael Scordo (131)
  4. Sergio Giralt (123)
  5. Saad Usmani (120)
  6. Alexander Lesokhin (111)

More People

Years
  1. 2025 (107)
  2. 2024 (365)
  3. 2023 (405)
  4. 2022 (323)
  5. 2021 (154)
  6. 2020 (73)

More Years

Publications
  1. Blood (249)
  2. Journal of Clinical Oncology (218)
  3. Clinical Lymphoma, Myeloma and Leukemia (46)
  4. Clinical Cancer Research (42)
  5. Annals of Oncology (37)
  6. Cancer Research (34)

More Publications

Publishers
  1. American Society of Hematology (285)
  2. American Society of Clinical Oncology (250)
  3. Elsevier Inc. (199)
  4. Nature Publishing Group (105)
  5. American Association for Cancer Research (100)
  6. Oxford University Press (69)

More Publishers

Results (1519)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States
    Journal Article

    Garg, S. K.; Kohli, K.; Garg, I. K.; Garg, Y. K.; Nguyen, L. G.; Nguyen, I. S.; Feliciano, E. J. G.; Baez, Y. A.; Mahal, B. A.; Iyengar, P.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Abida, W.; Chen, Y.; McHugh, D. J.; Morris, M. J.; Wu, F.; Peng, P.; Hennessy, K.; Wang, H.; Fan, J.; Zaidi, S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses
    Meeting Abstract

    Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Local definitive therapy (LDT) utilization patterns and outcomes in chromophobe renal cell carcinoma (chRCC) with metachronous metastasis: A multi-institution study
    Meeting Abstract

    Dizman, N.; Doshi, S. D.; Knezevic, A.; Feinaj, A.; Sayegh, N.; Hobeika, C.; Alaghehbandan, R.; Rives, H.; Zengin, Z. B.; Braun, D. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Investigation of ferroptosis and mTOR signaling in chromophobe renal cell carcinoma (ChRCC)
    Meeting Abstract

    Madsen, K. N.; Labaki, C.; Saad, E.; Alchoueiry, M.; Bi, K.; Hobeika, C.; Bakouny, Z.; Priolo, C.; Khabibullin, D.; Schindler, N. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
    Meeting Abstract

    Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes for radiographic node-positive prostate cancer following definitive radiotherapy
    Meeting Abstract

    Dodge, J.; Boe, L. A.; Boehm, K.; Guttmann, D.; Moore, Z.; Parikh, D.; Barsky, A.; Kollmeier, M.; McBride, S. M.; Brennan, V.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Correlation of NECTIN4 amplification and expression with response to enfortumab vedotin (EV) treatment in locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Yol, C.; Irawan, H.; Sternschuss, M.; Gupta, A.; Bent, E.; Basar, M.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Emerging importance of HER3 in tumorigenesis and cancer therapy
    Review

    Garrett, J. T.; Tendler, S.; Feroz, W.; Kilroy, M. K.; Yu, H.
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
    Journal Article

    Corona, M.; Ip, A.; Brown, S.; Luna, A.; Khatib, H.; Flynn, J. R.; Devlin, S. M.; Landego, I.; Cassanello, G.; Rejeski, K.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save